Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -12.66 % |
3 Month Return | -7.54 % |
1 Year Return | + 23.56 % |
Market Stats | |
Previous Close | ₹59.74 |
Open | ₹60.69 |
Volume | 33.00K |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹97.20Cr |
P/E Ratio | 0 |
PEG Ratio | 0 |
Market Cap | ₹97.20 Cr |
P/B Ratio | 5.39 |
EPS | 0 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 1.42 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹97.20 Cr | 165.24% | 0.51 | NA | NA | |
NA | ₹143.16 Cr | 73.55% | 0.56 | NA | NA | |
NA | ₹1,388.42 Cr | 84.92% | 0.51 | ₹25 Cr | ₹212 Cr | |
NA | ₹35.53 Cr | 14.76% | 0.54 | NA | NA | |
NA | ₹111.21 Cr | 51.29% | 0.55 | NA | NA |
Organisation | Biofil Chemicals & Pharmaceuticals Ltd |
Headquarters | |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Biofil Chemicals & Pharmaceuticals Ltd
Biofil Chemicals & Pharmaceuticals Ltd's share price has dropped by 17% in a month. The company's low earnings growth and dismal ROE suggest caution for investors.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 130.6% return, outperforming this stock by 124.1%
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 53.10% of holdings in Sep 2024 quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 58.6% return, outperforming this stock by 35.0%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 46.82% of holdings in Sep 2024 quarter
Price Dip
In the last 7 days, BIOFILCHEM stock has moved down by -4.5%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 46.82% | 0.00 | |
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 53.1% | 0.00 | |
Others | 0.08% | 0.12 |
Biofil Chemicals & Pharmaceuticals Ltd’s net profit fell -83.33% since last year same period to ₹0.02Cr in the Q2 2024-2025. On a quarterly growth basis, Biofil Chemicals & Pharmaceuticals Ltd has generated -88.24% fall in its net profits since last 3-months.
Read More about Earnings ResultsBearish
Neutral
Bullish
Biofil Chemicals & Pharmaceuticals Ltd is currently in a Bearish trading position according to technical analysis indicators.
Biofil Chemicals & Pharmaceuticals Ltd (BIOFILCHEM) share price today is ₹59.01
Biofil Chemicals & Pharmaceuticals Ltd is listed on NSE
Biofil Chemicals & Pharmaceuticals Ltd is listed on BSE
Today’s traded volume of Biofil Chemicals & Pharmaceuticals Ltd(BIOFILCHEM) is 33.00K.
Today’s market capitalisation of Biofil Chemicals & Pharmaceuticals Ltd(BIOFILCHEM) is ₹97.2Cr.
Biofil Chemicals & Pharmaceuticals Ltd(BIOFILCHEM | Price |
---|---|
52 Week High | ₹91.87 |
52 Week Low | ₹48.05 |
Biofil Chemicals & Pharmaceuticals Ltd(BIOFILCHEM) share price is ₹59.01. It is down -35.77% from its 52 Week High price of ₹91.87
Biofil Chemicals & Pharmaceuticals Ltd(BIOFILCHEM) share price is ₹59.01. It is up 22.81% from its 52 Week Low price of ₹48.05
Biofil Chemicals & Pharmaceuticals Ltd(BIOFILCHEM | Returns |
---|---|
1 Day Returns | -0.73% |
1 Month Returns | -12.66% |
3 Month Returns | -7.54% |
1 Year Returns | 23.56% |